Skip to main content
. Author manuscript; available in PMC: 2014 Jul 22.
Published in final edited form as: Cancer Cell. 2010 Dec 9;18(6):553–567. doi: 10.1016/j.ccr.2010.11.015

Figure 4. IDH1/2 mutations are mutually exclusive with mutations in TET2 in de novo AML.

Figure 4

(A) Circos diagram revealing relative frequency and pairwise co-occurrences of mutations in IDH1 and IDH2 in de novo AML. (B) Circos diagram revealing relative frequency and pairwise co-occurrences of mutations in TET2 in de novo AML. (C) Two-by-two table showing that mutations in IDH1/2 and TET2 were mutually exclusive in AML (Left-tailed Fisher p value: 0.009).